Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Dantrolene in the treatment of spasticity
A. D. Korczyn
, D. Galinsky
, V. M. Berginer
, C. Goren
Physiology Pharmacology
Tel Aviv University
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dantrolene in the treatment of spasticity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Active Substances
12%
Ancillary
12%
Central Nervous System
12%
Dantrolene
100%
Drug Use
12%
Gradual Increase
12%
Hepatic Damage
12%
Hyperactivity
12%
Mechanism of Action
12%
Passive Movement
12%
Placebo
50%
Self-care
12%
Spasticity
100%
Spontaneous Improvement
12%
Static State
12%
Tendon Reflex
12%
Pharmacology, Toxicology and Pharmaceutical Science
Dantrolene
100%
Hyperactivity
12%
Liver Injury
12%
Placebo
50%
Side Effect
12%
Spasticity
100%